2017 CBE Ancillary Business 150

We began the process of evaluating companies for The 2017 CBE Ancillary Business 150 back in May, using CBE Week to get the message out to its 30,000 plus subscribers that included a brief survey tracking company revenue performance for the last three years, as well as other proprietary information. CBE then pursued companies that we thought should be included in this year's list by speaking with companies directly that exhibit at industry trade shows throughout the summer, and then with yours truly, reaching out directly to company ownership via e-mails and phone calls to gather

Medical Cannabis Clinical Trials. October 6

Date: October 6, 2017

Time: 12.00 - 13.00

Details here..

October 6 at 12:00pm (EST)

Offit Kurman Cannabis Attorney, Jason Klein, will host “Medical Cannabis Clinical Trials” with presenter Christina DiArcangelo Puller, CEO and Founder of Affinity BioCeuticals (First PA Cannabis Biotech), who will share her insight on medical cannabis clinical trials.

The presentation will include:

Why clinical trials are important in the evolving cannabis industry
What the cannabis industry should do to promote responsible product claim while the FDA/FTC is silent
Practical guidance in conducting a clinical trial: time, money and resources
Why medical cannabis will be important for current conditions as an alternative to existing treatments
Eliminating addiction by supplementing medical cannabis for opioids